Synthetic biology for heparin biomanufacturing

Abstract

Heparin, mainly used as an anticoagulant, has also shown potential in the treatment of diseases such as inflammation and cancer. Currently, heparin is mainly extracted from the intestinal mucosa of pigs. However, due to concerns about disease transmission and contamination associated with animal-derived products, biomanufacturing techniques have been explored as alternative production methods. Through enzyme engineering, metabolic engineering, and synthetic biology approaches, the heparin biosynthetic pathways have been systematically optimized. The main biomanufacturing techniques include in vivo/in vitro combination strategy (microbial heparosan fermentation followed by chemoenzymatic modification) and de novo biosynthesis. This article comprehensively discusses the latest advancements, challenges, and future perspectives of these heparin biomanufacturing techniques.

Keywords

Bioengineered heparin / Heparosan fermentation / Chemoenzymatic modification / De novo biosynthesis / Synthetic biology

References

[1] Aikawa J, Esko JD. Molecular cloning and expression of a third member of the heparan sulfate/heparin GlcNAc N-deacetylase/ N-sulfotransferase family. J Biol Chem, 1999, 274(5): 2690-2695

[2] Aikawa J, Grobe K, Tsujimoto M, Esko JD. Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase. Structure and activity of the fourth member, NDST4. J Biol Chem, 2001, 276(8): 5876-5882

[3] An C, Zhao L, Wei Z, Zhou X. Chemoenzymatic synthesis of 3′-phosphoadenosine-5′-phosphosulfate coupling with an ATP regeneration system. Appl Microbiol Biotechnol, 2017, 101(20): 7535-7544

[4] Arnold K, Xu Y, Liao YE, Cooley BC, Pawlinski R, Liu J. Synthetic anticoagulant heparan sulfate attenuates liver ischemia reperfusion injury. Sci Rep, 2020, 10(1): 17187

[5] Badri A, Williams A, Xia K, Linhardt RJ, Koffas MA. Increased 3′-phosphoadenosine-5′-phosphosulfate levels in engineered Escherichia coli cell lysate facilitate the in vitro synthesis of chondroitin sulfate A. J Biotechnol, 2019, 1491800436

[6] Baik JY, Dahodwala H, Oduah E, Talman L, Gemmill TR, Gasimli L, Datta P, Yang B, Li G, Zhang F, Li L, Linhardt RJ, Campbell AM, Gorfien SF, Sharfstein ST. Optimization of bioprocess conditions improves production of a CHO cell-derived, bioengineered heparin. Biotechnol J, 2015, 1071067-1081

[7] Baik JY, Gasimli L, Yang B, Datta P, Zhang F, Glass CA, Esko JD, Linhardt RJ, Sharfstein ST. Metabolic engineering of Chinese hamster ovary cells: towards a bioengineered heparin. Metab Eng, 2012, 14(2): 81-90

[8] Baik JY, Wang CL, Yang B, Linhardt RJ, Sharfstein S. Toward a bioengineered heparin: challenges and strategies for metabolic engineering of mammalian cells. Bioengineered, 2012, 3(4): 227-231

[9] Barreteau H, Richard E, Drouillard S, Samain E, Priem B. Production of intracellular heparosan and derived oligosaccharides by lyase expression in metabolically engineered E. coli K-12. Carbohydr Res, 2012, 360: 19-24

[10] Baytas SN, Linhardt RJ. Advances in the preparation and synthesis of heparin and related products. Drug Discov Today, 2020, 25(12): 2095-2109

[11] Berger I, Guttman C, Amar D, Zarivach R, Aharoni A. The molecular basis for the broad substrate specificity of human sulfotransferase 1A1. PLoS ONE, 2011, 6(11): e26794

[12] Bethea HN, Xu D, Liu J, Pedersen LC. Redirecting the substrate specificity of heparan sulfate 2-O-sulfotransferase by structurally guided mutagenesis. PNAS, 2008, 1054818724-18729

[13] Bhaskar U, Li G, Fu L, Onishi A, Suflita M, Dordick JS, Linhardt RJ. Combinatorial one-pot chemoenzymatic synthesis of heparin. Carbonhydr Polym, 2015, 122: 399-407

[14] Bhaskar U, Sterner E, Hickey AM, Onishi A, Zhang F, Dordick JS, Linhardt RJ. Engineering of routes to heparin and related polysaccharides. Appl Microbiol Biotechnol, 2012, 93(1): 1-16

[15] Burdock GA, Carabin IG. Generally recognized as safe (GRAS): history and description. Toxicol Lett, 2004, 150(1): 3-18

[16] Cai C, Dickinson DM, Li L, Masuko S, Suflita M, Schultz V, Nelson SD, Bhaskar U, Liu J, Linhardt RJ. Fluorous-assisted chemoenzymatic synthesis of heparan sulfate oligosaccharides. Org Lett, 2014, 16(8): 2240-2243

[17] Cao YL, Deng JQ, Li Y, Xin SY, Chen YJ, Li XY, Cao HZ, Guo XP, Wang FS, Sheng JZ. N-difluoroacetylhexosamine as a substrate-engineering precursor for glycosylation reactions. Org Lett, 2024, 26(36): 7739-7743

[18] Capila I, Linhardt RJ. Heparin-protein interactions. Angew Chem Int Ed Engl, 2002, 41(3): 391-412

[19] Chandarajoti K, Xu Y, Sparkenbaugh E, Key NS, Pawlinski R, Liu J. De novo synthesis of a narrow size distribution low-molecular-weight heparin. Glycobiology, 2014, 24(5): 476-486

[20] Chavaroche AA, Springer J, Kooy F, Boeriu C, Eggink G. In vitro synthesis of heparosan using recombinant Pasteurella multocida heparosan synthase PmHS2.. Appl Microbiol Biotechnol, 2010, 85(6): 1881-1891

[21] Chen J, Avci FY, Muñoz EM, McDowell LM, Chen M, Pedersen LC, Zhang L, Linhardt RJ, Liu J. Enzymatic redesigning of biologically active heparan sulfate. J Biol Chem, 2005, 280(52): 42817-42825

[22] Chen J, Duncan MB, Carrick K, Pope RM, Liu J. Biosynthesis of 3-O-sulfated heparan sulfate: unique substrate specificity of heparan sulfate 3-O-sulfotransferase isoform 5. Glycobiology, 2003, 13(11): 785-794

[23] Chen X, Chen R, Yu X, Tang D, Yao W, Gao X. Metabolic engineering of Bacillus subtilis for biosynthesis of heparosan using heparosan synthase from Pasteurella multocida, PmHS1. Bioprocess Biosyst Eng, 2017, 40(5): 675-681

[24] Chen Y, Wan Z, Li ZJ (2025) Development of Sucrose-Utilizing Escherichia coli Nissle 1917 for Efficient Heparosan Biosynthesis. Metabolites 15(6):410. https://doi.org/10.3390/metabo15060410

[25] Datta P, Fu L, He W, Koffas M, Dordick J, Linhardt R. Expression of enzymes for 3′-phosphoadenosine-5′-phosphosulfate (PAPS) biosynthesis and their preparation for PAPS synthesis and regeneration. Appl Microbiol Biotechnol, 2020, 104(16): 7067-7078

[26] Datta P, Li G, Yang B, Zhao X, Baik JY, Gemmill TR, Sharfstein ST, Linhardt RJ. Bioengineered Chinese hamster ovary cells with Golgi-targeted 3-O-sulfotransferase-1 biosynthesize heparan sulfate with an antithrombin-binding site. J Biol Chem, 2013, 288(52): 37308-37318

[27] DeAngelis PL, Gunay NS, Toida T, Mao W-j, Linhardt RJ. Identification of the capsular polysaccharides of Type D and F Pasteurella multocida as unmodified heparin and chondroitin, respectively. Carbohydr Res, 2002, 337(17): 1547-1552

[28] Debarnot C, Monneau YR, Roig-Zamboni V, Delauzun V, Le Narvor C, Richard E, Hénault J, Goulet A, Fadel F, Vivès RR, Priem B, Bonnaffé D, Lortat-Jacob H, Bourne Y. Substrate binding mode and catalytic mechanism of human heparan sulfate d-glucuronyl C5 epimerase. Proc Natl Acad Sci USA, 2019, 116(14): 6760-6765

[29] Deligny A, Dierker T, Dagälv A, Lundequist A, Eriksson I, Nairn AV, Moremen KW, Merry CLR, Kjellén L. NDST2 (N-deacetylase/N-sulfotransferase-2) enzyme regulates heparan sulfate chain length. J Biol Chem, 2016, 291(36): 18600-18607

[30] Deng JQ, Li Y, Wang YJ, Cao YL, Xin SY, Li XY, Xi RM, Wang FS, Sheng JZ. Biosynthetic production of anticoagulant heparin polysaccharides through metabolic and sulfotransferases engineering strategies. Nat Commun, 2024, 15(1): 3755

[31] Deng J-Q, Lu Z, Liu J, Zhao Y, Hou X, Guo X-P, Jiang W-J, Wang F, Sheng J-z. Heparosan oligosaccharide synthesis using engineered single-function glycosyltransferases. Catal Sci Technol, 2022

[32] Dey S, Lo HJ, Wong CH. Programmable one-pot synthesis of heparin pentasaccharide fondaparinux. Org Lett, 2020, 22124638-4642

[33] Dombrovski L, Dong A, Bochkarev A, Plotnikov AN. Crystal structures of human sulfotransferases SULT1B1 and SULT1C1 complexed with the cofactor product adenosine-3'- 5'-diphosphate (PAP). Proteins, 2006, 64(4): 1091-1094

[34] Douaisi M, Paskaleva EE, Fu L, Grover N, McManaman CL, Varghese S, Brodfuehrer PR, Gibson JM, de Joo I, Xia K, Brier MI, Simmons TJ, Datta P, Zhang F, Onishi A, Hirakane M, Mori D, Linhardt RJ, Dordick JS. Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin. PNAS, 2024, 121(14): e2315586121

[35] Dou W, Xu Y, Pagadala V, Pedersen LC, Liu J. Role of deacetylase activity of N-deacetylase/N-sulfotransferase 1 in forming N-sulfated domain in heparan sulfate. J Biol Chem, 2015, 2903320427-20437

[36] Dulaney SB, Huang X. Strategies in synthesis of heparin/heparan sulfate oligosaccharides: 2000-present. Adv Carbohydr Chem Biochem, 2012, 67: 95-136

[37] Gamage NU, Duggleby RG, Barnett AC, Tresillian M, Latham CF, Liyou NE, McManus ME, Martin JL. Structure of a human carcinogen-converting enzyme, SULT1A1. Structural and kinetic implications of substrate inhibition. J Biol Chem, 2003, 278(9): 7655-7662

[38] Gao D, Liu T, Gao J, Xu J, Gou Y, Pan Y, Li D, Ye C, Pan R, Huang L, Xu Z, Lian J. De novo biosynthesis of vindoline and catharanthine in Saccharomyces cerevisiae. BioDesign Res, 2022, 2022: 0002

[39] Gasimli L, Glass CA, Datta P, Yang B, Li G, Gemmill TR, Baik JY, Sharfstein ST, Esko JD, Linhardt RJ. Bioengineering murine mastocytoma cells to produce anticoagulant heparin. Glycobiology, 2013, 24(3): 272-280

[40] Gebo JE, East AD, Lau AF. A side-by-side comparison of clinical versus current good manufacturing practices (cGMP) microbiology laboratory requirements for sterility testing of cellular and gene therapy products. Clin Microbiol Newsl, 2021, 43(21): 181-191

[41] Gray E, Hogwood J, Mulloy B (2012) The anticoagulant and antithrombotic mechanisms of heparin. In: Lever R, Mulloy B, Page CP (eds) Heparin - A Century of Progress. Springer Berlin Heidelberg, pp 43–61. https://doi.org/10.1007/978-3-642-23056-1_3

[42] Guerrini M, Beccati D, Shriver Z, Naggi A, Viswanathan K, Bisio A, Capila I, Lansing JC, Guglieri S, Fraser B, Al-Hakim A, Gunay NS, Zhang Z, Robinson L, Buhse L, Nasr M, Woodcock J, Langer R, Venkataraman G, Linhardt RJ, Casu B, Torri G, Sasisekharan R. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol, 2008, 26(6): 669-675

[43] Guhan S, Raj N, Sivaprakasam S, Jeeva P (2022) Metabolic Engineering Of Lactococcus Lactis For The Production Of Heparosan. bioRxiv:2022.2012. 2028.522110

[44] Gu S, Zhang F, Li Z, Qi H, Huang L, Liu K, Song W, Wei W, Gao C, Hu G, Li X, Liu L. Engineering a novel adenine-sulfotransferase for efficient synthesis of PAPS and chondroitin sulfate in microbial cells. Trends Biotechnol, 2025, 43(10): 2609-2626

[45] Habuchi H, Tanaka M, Habuchi O, Yoshida K, Suzuki H, Ban K, Kimata K. The occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamine. J Biol Chem, 2000, 275(4): 2859-2868

[46] Hagner-McWhirter A, Li JP, Oscarson S, Lindahl U. Irreversible glucuronyl C5-epimerization in the biosynthesis of heparan sulfate. J Biol Chem, 2004, 279(15): 14631-14638

[47] Hemker HC, Al Dieri R, Béguin S. Heparins: a shift of paradigm. Front Med, 2019, 6: 254

[48] Hodson N, Griffiths G, Cook N, Pourhossein M, Gottfridson E, Lind T, Lidholt K, Roberts IS. Identification that KfiA, a protein essential for the biosynthesis of the Escherichia coli K5 capsular polysaccharide, is an α-UDP-GlcNac glycosyltransferase: the formation of a membrane-associated K5 biosynthetic complex requires KfiA, KfiB, and KfiC. J Biol Chem, 2000, 275(35): 27311-27315

[49] Huang Y, Mao Y, Zong C, Lin C, Boons GJ, Zaia J. Discovery of a heparan sulfate 3-O-sulfation specific peeling reaction. Anal Chem, 2015, 87(1): 592-600

[50] Hubbard S, Darmani NA, Thrush GR, Dey D, Burnham L, Thompson JM, Jones K, Tiwari V. Zebrafish-encoded 3-O-sulfotransferase-3 isoform mediates herpes simplex virus type 1 entry and spread. Zebrafish, 2010, 7(2): 181-187

[51] Hu L, Wang Y, Hu Y, Yin J, Wang L, Du G, Chen J, Kang Z. Biosynthesis of non-sulfated high-molecular-weight glycosaminoglycans and specific-sized oligosaccharides. Carbohydr Polym, 2022, 295: 119829

[52] Hu S, Zhao L, Hu L, Xi X, Zhang Y, Wang Y, Chen J, Chen J, Kang Z. Engineering the probiotic bacterium Escherichia coli Nissle 1917 as an efficient cell factory for heparosan biosynthesis. Enzyme Microb Technol, 2022, 158: 110038

[53] Hu S, Zhou S, Wang Y, Chen W, Yin G, Chen J, Du G, Kang Z. Coordinated optimization of the polymerization and transportation processes to enhance the yield of exopolysaccharide heparosan. Carbohydr Polym, 2024, 333: 121983

[54] Huynh MB, Rebergue N, Merrick H, Gomez-Henao W, Jospin E, Biard DSF, Papy-Garcia D. HS3ST2 expression induces the cell autonomous aggregation of tau. Sci Rep, 2022, 12(1): 10850

[55] Javot L, Lecompte T, Rabiskova M, Maincent P. Encapsulation of low molecular weight heparins: influence on the anti-Xa/anti-IIa ratio. J Control Release, 2009, 13918-14

[56] Jeanneret RA, Dalton CE, Gardiner JM. Synthesis of heparan sulfate- and dermatan sulfate-related oligosaccharides via iterative chemoselective glycosylation exploiting conformationally disarmed [2.2.2] l-iduronic lactone thioglycosides. J Org Chem, 2019, 84(23): 15063-15078

[57] Jemth P, Smeds E, Do AT, Habuchi H, Kimata K, Lindahl U, Kusche-Gullberg M. Oligosaccharide library-based assessment of heparan sulfate 6-O-sulfotransferase substrate specificity. J Biol Chem, 2003, 278(27): 24371-24376

[58] Jiang X, Zhang B, Cai X, Liu Z, Zheng Y. Progress on the synthesis of bioengineered heparin as an alternative to animal-derived heparin active pharmaceutical ingredient. Carbohydr Polym, 2025

[59] Jin P, Zhang L, Yuan P, Kang Z, Du G, Chen J. Efficient biosynthesis of polysaccharides chondroitin and heparosan by metabolically engineered Bacillus subtilis. Carbohydr Polym, 2016, 140: 424-432

[60] Jin X, Zhang W, Wang Y, Sheng J, Xu R, Li J, Du G, Kang Z. Biosynthesis of non-animal chondroitin sulfate from methanol using genetically engineered Pichia pastoris. Green Chem, 2021, 23(12): 4365-4374

[61] Kakuta Y, Sueyoshi T, Negishi M, Pedersen LC. Crystal structure of the sulfotransferase domain of human heparan sulfate N-deacetylase/ N-sulfotransferase 1. J Biol Chem, 1999, 274(16): 10673-10676

[62] Karlsson R, Chopra P, Joshi A, Yang Z, Vakhrushev SY, Clausen TM, Painter CD, Szekeres GP, Chen YH, Sandoval DR, Hansen L, Esko JD, Pagel K, Dyer DP, Turnbull JE, Clausen H, Boons GJ, Miller RL. Dissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfates. Sci Adv, 2021, 7(52): eabl6026

[63] Kishimoto TK, Viswanathan K, Ganguly T, Elankumaran S, Smith S, Pelzer K, Lansing JC, Sriranganathan N, Zhao G, Galcheva-Gargova Z. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med, 2008, 358232457-2467

[64] Kobayashi M, Habuchi H, Habuchi O, Saito M, Kimata K. Purification and characterization of heparan sulfate 2-sulfotransferase from cultured Chinese hamster ovary cells. J Biol Chem, 1996, 271(13): 7645-7653

[65] Kobayashi M, Sugumaran G, Liu J, Shworak NW, Silbert JE, Rosenberg RD. Molecular cloning and characterization of a human uronyl 2-sulfotransferase that sulfates iduronyl and glucuronyl residues in dermatan/chondroitin sulfate. J Biol Chem, 1999, 274(15): 10474-10480

[66] Koprivova A, Kopriva S. Sulfation pathways in plants. Chem Biol Interact, 2016, 259(Pt A): 23-30

[67] Kreuger J, Salmivirta M, Sturiale L, Giménez-Gallego G, Lindahl U. Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. J Biol Chem, 2001, 276(33): 30744-30752

[68] Kreuger J, Spillmann D, Li JP, Lindahl U. Interactions between heparan sulfate and proteins: the concept of specificity. J Cell Biol, 2006, 174(3): 323-327

[69] Kuberan B, Beeler DL, Lech M, Wu ZL, Rosenberg RD. Chemoenzymatic synthesis of classical and non-classical anticoagulant heparan sulfate polysaccharides. J Biol Chem, 2003, 278(52): 52613-52621

[70] Kuberan B, Lech MZ, Beeler DL, Wu ZL, Rosenberg RD. Enzymatic synthesis of antithrombin III-binding heparan sulfate pentasaccharide. Nat Biotechnol, 2003, 21(11): 1343-1346

[71] Kulkarni SS, Wang CC, Sabbavarapu NM, Podilapu AR, Liao PH, Hung SC. "One-Pot" protection, glycosylation, and protection-glycosylation strategies of carbohydrates. Chem Rev, 2018, 118(17): 8025-8104

[72] Leroux M, Priem B. Chaperone-assisted expression of KfiC glucuronyltransferase from Escherichia coli K5 leads to heparosan production in Escherichia coli BL21 in absence of the stabilisator KfiB. Appl Microbiol Biotechnol, 2016, 100(24): 10355-10361

[73] Lidholt K, Riesenfeld J, Jacobsson KG, Feingold DS, Lindahl U. Biosynthesis of heparin. Modulation of polysaccharide chain length in a cell-free system. Biochem J, 1988, 254(2): 571-578

[74] Li J, Hagner-McWhirter A, Kjellén L, Palgi J, Jalkanen M, Lindahl U. Biosynthesis of heparin/heparan sulfate. cDNA cloning and expression of D-glucuronyl C5-epimerase from bovine lung. J Biol Chem, 1997, 272(44): 28158-28163

[75] Li JP. Glucuronyl C5-epimerase an enzyme converting glucuronic acid to iduronic acid in heparan sulfate/heparin biosynthesis. Prog Mol Biol Transl Sci, 2010, 93: 59-78

[76] Li J, Su G, Xu Y, Arnold K, Pagadala V, Wang C, Liu J. Synthesis of 3-O-sulfated heparan sulfate oligosaccharides using 3-O-sulfotransferase isoform 4. ACS Chem Biol, 2021, 16(10): 2026-2035

[77] Linhardt R. Heparin: structure and activity. J Med Chem, 2003, 46: 2551-2554

[78] Liu C, Sheng J, Krahn JM, Perera L, Xu Y, Hsieh PH, Dou W, Liu J, Pedersen LC. Molecular mechanism of substrate specificity for heparan sulfate 2-O-sulfotransferase. J Biol Chem, 2014, 289(19): 13407-13418

[79] Liu H, Wei W, Pang Z, Gu S, Song W, Gao C, Chen X, Liu J, Guo L, Wu J, Liu L. Protein engineering, cofactor engineering, and surface display engineering to achieve whole-cell catalytic production of chondroitin sulfate A. Biotechnol Bioeng, 2023, 120(7): 1784-1796

[80] Liu J, Pedersen LC. Emerging chemical and biochemical tools for studying 3-O-sulfated heparan sulfate. Am J Physiol Cell Physiol, 2022, 322(6): C1166-c1175

[81] Liu J, Shworak NW, Sinaÿ P, Schwartz JJ, Zhang L, Fritze LM, Rosenberg RD. Expression of heparan sulfate D-glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate specificities. J Biol Chem, 1999, 274(8): 5185-5192

[82] Liu K, Chen X, Zhong Y, Gao C, Hu G, Liu J, Guo L, Song W, Liu L. Rational design of a highly efficient catalytic system for the production of PAPS from ATP and its application in the synthesis of chondroitin sulfate. Biotechnol Bioeng, 2021, 118(11): 4503-4515

[83] Liu K, Guo L, Chen X, Liu L, Gao C. Microbial synthesis of glycosaminoglycans and their oligosaccharides. Trends Microbiol, 2023, 31(4): 369-383

[84] Liu T, Gou Y, Zhang B, Gao R, Dong C, Qi M, Jiang L, Ding X, Li C, Lian J. Construction of ajmalicine and sanguinarine de novo biosynthetic pathways using stable integration sites in yeast. Biotechnol Bioeng, 2022, 119(5): 1314-1326

[85] Liu Y, Liu L, Chen J, Li J, Du G, Chen J. Effects of carbon sources and feeding strategies on heparosan production by Escherichia coli K5. Bioprocess Biosyst Eng, 2012, 35(7): 1209-1218

[86] Liu Z-Y, Yu X-Z. Engineering Bacillus subtilis for high-value bioproduction: recent advances and applications. Microb Cell Fact, 2025, 24(1): 182

[87] Li X (2016) Studies on efficient preparation of several key enzymes and its mutienzymatic reaction engineering for heparin biosynthesis. Doctoral dissertation, Zhejiang University

[88] Li XY, Deng JQ, Zhao YH, Cao YL, Li Y, Hou J, Guo XP, Sheng JZ. Optimized 3'-phosphoadenosine-5'-phosphosulfate biosynthesis via yeast-powered ATP regeneration and biotin-streptavidin enzyme immobilization. Biochemistry, 2025, 64194232-4241

[89] Li YJ, Yin FX, Zhang XK, Yu J, Zheng S, Song XL, Wang FS, Sheng JZ. Characterization of heparan sulfate N-deacetylase/N-sulfotransferase isoform 4 using synthetic oligosaccharide substrates. Biochim Biophys Acta, 2018, 1862(3): 547-556

[90] Lord MS, Cheng B, Tang F, Lyons JG, Rnjak-Kovacina J, Whitelock JM. Bioengineered human heparin with anticoagulant activity. Metab Eng, 2016, 38: 105-114

[91] Lu W, Zong C, Chopra P, Pepi LE, Xu Y, Amster IJ, Liu J, Boons GJ. Controlled chemoenzymatic synthesis of heparan sulfate oligosaccharides. Angew Chem Int Ed Engl, 2018, 57(19): 5340-5344

[92] Malojcić G, Owen RL, Grimshaw JP, Brozzo MS, Dreher-Teo H, Glockshuber R. A structural and biochemical basis for PAPS-independent sulfuryl transfer by aryl sulfotransferase from uropathogenic Escherichia coli. PNAS, 2008, 105(49): 19217-19222

[93] Ma S, Su T, Lu X, Qi Q. Bacterial genome reduction for optimal chassis of synthetic biology: a review. Crit Rev Biotechnol, 2024, 44(4): 660-673

[94] McLellan MA, Rosenthal NA, Pinto AR. Cre-loxP-mediated recombination: general principles and experimental considerations. Curr Protoc Mouse Biol, 2017, 7(1): 1-12

[95] Mochizuki H, Yamagishi K, Suzuki K, Kim YS, Kimata K. Heparosan-glucuronate 5-epimerase: molecular cloning and characterization of a novel enzyme. Glycobiology, 2015, 25(7): 735-744

[96] Moon AF, Edavettal SC, Krahn JM, Munoz EM, Negishi M, Linhardt RJ, Liu J, Pedersen LC. Structural analysis of the sulfotransferase (3-o-sulfotransferase isoform 3) involved in the biosynthesis of an entry receptor for herpes simplex virus 1. J Biol Chem, 2004, 279(43): 45185-45193

[97] Moon AF, Xu Y, Woody SM, Krahn JM, Linhardt RJ, Liu J, Pedersen LC. Dissecting the substrate recognition of 3-O-sulfotransferase for the biosynthesis of anticoagulant heparin. PNAS, 2012, 109(14): 5265-5270

[98] Mueller JW, Shafqat N. Adenosine-5'-phosphosulfate–a multifaceted modulator of bifunctional 3'-phospho-adenosine-5'-phosphosulfate synthases and related enzymes. FEBS J, 2013, 280(13): 3050-3057

[99] Mycroft-West CJ, Abdelkarim S, Duyvesteyn HME, Gandhi NS, Skidmore MA, Owens RJ, Wu L. Structural and mechanistic characterization of bifunctional heparan sulfate N-deacetylase-N-sulfotransferase 1. Nat Commun, 2024, 15(1): 1326

[100] Nehru G, Balakrishnan R, Swaminathan N, Tadi SRR, Sivaprakasam S (2024) Heparosan biosynthesis in recombinant Bacillus megaterium: Influence of N-acetylglucosamine supplementation and kinetic modeling. Biotechnol Appl Biochem 71(6):1346–1359. https://doi.org/10.1002/bab.2634

[101] Nehru G, Tadi SRR, Limaye AM, Sivaprakasam S. Production and characterization of low molecular weight heparosan in Bacillus megaterium using Escherichia coli K5 glycosyltransferases. Int J Biol Macromol, 2020, 160: 69-76

[102] Nehru G, Tadi SRR, Sivaprakasam S. Application of dual promoter expression system for the enhanced heparosan production in Bacillus megaterium. Appl Biochem Biotechnol, 2021, 193(8): 2389-2402

[103] Nikolovska K, Spillmann D, Seidler DG. Uronyl 2-O sulfotransferase potentiates Fgf2-induced cell migration. J Cell Sci, 2015, 128(3): 460-471

[104] O'Donnell CD, Tiwari V, Oh MJ, Shukla D. A role for heparan sulfate 3-O-sulfotransferase isoform 2 in herpes simplex virus type 1 entry and spread. Virology, 2006, 346(2): 452-459

[105] Ohka S, Yamada S, Nishizawa D, Fukui Y, Arita H, Hanaoka K, Iseki M, Kato J, Ogawa S, Hiranuma A, Kasai S, Hasegawa J, Hayashida M, Fukushi S, Saijo M, Ikeda AK. Heparan sulfate 3-O-sulfotransferase 4 is genetically associated with herpes zoster and enhances varicella-zoster virus-mediated fusogenic activity. Mol Pain, 2021, 17: 17448069211052171

[106] Otto NJ, Green DE, Masuko S, Mayer A, Tanner ME, Linhardt RJ, DeAngelis PL. Structure/function analysis of Pasteurella multocida heparosan synthases: toward defining enzyme specificity and engineering novel catalysts. J Biol Chem, 2012, 287(10): 7203-7212

[107] Pal U, Bachmann D, Pelzer C, Christiansen J, Blank LM, Tiso T. A genetic toolbox to empower Paracoccus pantotrophus DSM 2944 as a metabolically versatile SynBio chassis. Microb Cell Fact, 2024, 23(1): 53

[108] Pikas DS, Eriksson I, Kjellén L. Overexpression of different isoforms of glucosaminyl N-deacetylase/N-sulfotransferase results in distinct heparan sulfate N-sulfation patterns. Biochemistry, 2000, 39154552-4558

[109] Pinhal MA, Smith B, Olson S, Aikawa J, Kimata K, Esko JD. Enzyme interactions in heparan sulfate biosynthesis: uronosyl 5-epimerase and 2-O-sulfotransferase interact in vivo. PNAS, 2001, 98(23): 12984-12989

[110] Pouresmaeil M, Azizi-Dargahlou S. Factors involved in heterologous expression of proteins in E. coli host. Arch Microbiol, 2023, 205(5): 212

[111] Put H, Gerstmans H, Vande Capelle H, Fauvart M, Michiels J, Masschelein J. Bacillus subtilis as a host for natural product discovery and engineering of biosynthetic gene clusters. Nat Prod Rep, 2024, 4171113-1151

[112] Qin Y, Ke J, Gu X, Fang J, Wang W, Cong Q, Li J, Tan J, Brunzelle JS, Zhang C, Jiang Y, Melcher K, Li JP, Xu HE, Ding K. Structural and functional study of D-glucuronyl C5-epimerase. J Biol Chem, 2015, 290(8): 4620-4630

[113] Raedts J, Lundgren M, Kengen SW, Li JP, van der Oost J. A novel bacterial enzyme with D-glucuronyl C5-epimerase activity. J Biol Chem, 2013, 288(34): 24332-24339

[114] Roy A, Miyai Y, Rossi A, Paraswar K, Desai UR, Saijoh Y, Kuberan B. Metabolic engineering of non-pathogenic Escherichia coli strains for the controlled production of low molecular weight heparosan and size-specific heparosan oligosaccharides. Biochim Biophys Acta, 2021, 1865(1): 129765

[115] Saribaş AS, Mobasseri A, Pristatsky P, Chen X, Barthelson R, Hakes D, Wang J. Production of N-sulfated polysaccharides using yeast-expressed N-deacetylase/N-sulfotransferase-1 (NDST-1). Glycobiology, 2004, 14121217-1228

[116] Sarnaik A, Abernathy MH, Han X, Ouyang Y, Xia K, Chen Y, Cress B, Zhang F, Lali A, Pandit R (2019) Metabolic engineering of cyanobacteria for photoautotrophic production of heparosan, a pharmaceutical precursor of heparin. Algal Res 37:57–63. https://doi.org/10.1016/j.algal.2018.11.010

[117] Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A, Linhardt RJ, Mohammadi M. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell, 2000, 6(3): 743-750

[118] Schwartz NB, Domowicz MS. Chemistry and function of glycosaminoglycans in the nervous system. Adv Neurobiol, 2014, 9: 89-115

[119] Shao F, Wu R, Li ZJ. Enhanced heparosan biosynthesis in Escherichia coli Nissle 1917 through carbon flux redirection. J Biosci Bioeng, 2025, 140(4): 193-199

[120] Sheng J, Liu R, Xu Y, Liu J. The dominating role of N-deacetylase/N-sulfotransferase 1 in forming domain structures in heparan sulfate. J Biol Chem, 2011, 286(22): 19768-19776

[121] Sheng J, Xu Y, Dulaney SB, Huang X, Liu J. Uncovering biphasic catalytic mode of C5-epimerase in heparan sulfate biosynthesis. J Biol Chem, 2012, 287(25): 20996-21002

[122] Sheng L-L, Cai Y-M, Li Y, Huang S-L, Sheng J-Z. Advancements in heparosan production through metabolic engineering and improved fermentation. Carbohydr Polym, 2024, 331: 121881

[123] Shi L. Bioactivities, isolation and purification methods of polysaccharides from natural products: a review. Int J Biol Macromol, 2016, 92: 37-48

[124] Shworak NW, Liu J, Petros LM, Zhang L, Kobayashi M, Copeland NG, Jenkins NA, Rosenberg RD. Multiple isoforms of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. Isolation, characterization, and expression of human cdnas and identification of distinct genomic loci. J Biol Chem, 1999, 274(8): 5170-5184

[125] Thacker BE, Thorne KJ, Cartwright C, Park J, Glass K, Chea A, Kellman BP, Lewis NE, Wang Z, Di Nardo A, Sharfstein ST, Jeske W, Walenga J, Hogwood J, Gray E, Mulloy B, Esko JD, Glass CA. Multiplex genome editing of mammalian cells for producing recombinant heparin. Metab Eng, 2022, 70: 155-165

[126] Thacker BE, Xu D, Lawrence R, Esko JD. Heparan sulfate 3-O-sulfation: a rare modification in search of a function. Matrix Biol, 2014, 35: 60-72

[127] Thomas D, Surdin-Kerjan Y. Metabolism of sulfur amino acids in Saccharomyces cerevisiae. Microbiol Mol Biol Rev, 1997, 61(4): 503-532

[128] Tiwari V, Clement C, Duncan MB, Chen J, Liu J, Shukla D. A role for 3-O-sulfated heparan sulfate in cell fusion induced by herpes simplex virus type 1. J Gen Virol, 2004, 85(Pt 4): 805-809

[129] Vann WF, Schmidt MA, Jann B, Jann K. The structure of the capsular polysaccharide (K5 Antigenn) of urinary-tract-infective Escherichia coli 010: K5: H4: a polymer similar to desulfo-heparin. Eur J Biochem, 1981, 116(2): 359-364

[130] Venkatachalam KV. Human 3'-phosphoadenosine 5'-phosphosulfate (PAPS) synthase: biochemistry, molecular biology and genetic deficiency. IUBMB Life, 2003, 55(1): 1-11

[131] Vilanova E, Tovar AMF, Mourão PAS. Imminent risk of a global shortage of heparin caused by the African Swine Fever afflicting the Chinese pig herd. J Thromb Haemost, 2019, 17(2): 254-256

[132] Viskov C, Lux F, Gervier R, Colas G (2008) US Patent 2008/0032349

[133] Wander R, Kaminski AM, Xu Y, Pagadala V, Krahn JM, Pham TQ, Liu J, Pedersen LC. Deciphering the substrate recognition mechanisms of the heparan sulfate 3-O-sulfotransferase-3. RSC Chem Biol, 2021, 2(4): 1239-1248

[134] Wang TT, Deng JQ, Chen LZ, Sun L, Wang FS, Ling PX, Sheng JZ. The second member of the bacterial UDP-N-acetyl-D-glucosamine: heparosan alpha-1, 4-N-acetyl-D-glucosaminyltransferase superfamily: GaKfiA from Gallibacterium anatis. Int J Biol Macromol, 2020, 147: 170-176

[135] Wang Y, Hu L, Huang H, Wang H, Zhang T, Chen J, Du G, Kang Z. Eliminating the capsule-like layer to promote glucose uptake for hyaluronan production by engineered Corynebacterium glutamicum. Nat Commun, 2020, 11(1): 3120

[136] Wang Z, Hsieh PH, Xu Y, Thieker D, Chai EJE, Xie S, Cooley B, Woods RJ, Chi L, Liu J. Synthesis of 3-O-sulfated oligosaccharides to understand the relationship between structures and functions of heparan sulfate. J Am Chem Soc, 2017, 139145249-5256

[137] Wang Z, Li J, Cheong S, Bhaskar U, Akihiro O, Zhang F, Dordick JS, Linhardt RJ. Response surface optimization of the heparosan N-deacetylation in producing bioengineered heparin. J Biotechnol, 2011, 156(3): 188-196

[138] Wang Z, Ly M, Zhang F, Zhong W, Suen A, Hickey AM, Dordick JS, Linhardt RJ. E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor. Biotechnol Bioeng, 2010, 107(6): 964-973

[139] Wang Z, Yang B, Zhang Z, Ly M, Takieddin M, Mousa S, Liu J, Dordick JS, Linhardt RJ. Control of the heparosan N-deacetylation leads to an improved bioengineered heparin. Appl Microbiol Biotechnol, 2011, 91(1): 91-99

[140] Wei Z, Swiedler SJ, Ishihara M, Orellana A, Hirschberg CB. A single protein catalyzes both N-deacetylation and N-sulfation during the biosynthesis of heparan sulfate. PNAS, 1993, 90(9): 3885-3888

[141] Whelihan MF, Cooley B, Xu Y, Pawlinski R, Liu J, Key NS. In vitro and in vivo characterization of a reversible synthetic heparin analog. Thromb Res, 2016, 138: 121-129

[142] Whitfield C, Wear SS, Sande C. Assembly of bacterial capsular polysaccharides and exopolysaccharides. Annu Rev Microbiol, 2020, 74(1): 521-543

[143] Williams A, Gedeon KS, Vaidyanathan D, Yu Y, Collins CH, Dordick JS, Linhardt RJ, Koffas MAG. Metabolic engineering of Bacillus megaterium for heparosan biosynthesis using Pasteurella multocida heparosan synthase, PmHS2. Microb Cell Fact, 2019, 18(1): 132

[144] Witt RM, Hecht ML, Pazyra-Murphy MF, Cohen SM, Noti C, van Kuppevelt TH, Fuller M, Chan JA, Hopwood JJ, Seeberger PH, Segal RA. Heparan sulfate proteoglycans containing a glypican 5 core and 2-O-sulfo-iduronic acid function as Sonic Hedgehog co-receptors to promote proliferation. J Biol Chem, 2013, 2883626275-26288

[145] Wu B, Wei N, Thon V, Wei M, Yu Z, Xu Y, Chen X, Liu J, Wang PG, Li T. Facile chemoenzymatic synthesis of biotinylated heparosan hexasaccharide. Org Biomol Chem, 2015, 13(18): 5098-5101

[146] Wu J, Jiang L, Liu J, Wang H, Gao Q, Huan C, Wang X, Gao S. Comparison of the safety and efficacy of the wild-type and lpxL/lpxM mutant inactivated vaccine against the avian pathogenic Escherichia coli O1, O2, and O78 challenge. Vaccine, 2024, 42(10): 2707-2715

[147] Wu JR, Chen PY, Shien JH, Shyu CL, Shieh HK, Chang F, Chang PC. Analysis of the biosynthesis genes and chemical components of the capsule of Avibacterium paragallinarum. Vet Microbiol, 2010, 145(1–2): 90-99

[148] Wu Q, Cho JG, Lee DS, Lee DY, Song NY, Kim YC, Lee KT, Chung HG, Choi MS, Jeong TS, Ahn EM, Kim GS, Baek NI. Carbohydrate derivatives from the roots of Brassica rapa ssp. campestris and their effects on ROS production and glutamate-induced cell death in HT-22 cells. Carbohydr Res, 2013, 372: 9-14

[149] Xia G, Chen J, Tiwari V, Ju W, Li JP, Malmstrom A, Shukla D, Liu J. Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1. J Biol Chem, 2002, 277(40): 37912-37919

[150] Xiao F, Li D, Pan Y, Lv B, Gao J, Zuo Y, Huang L, Lian J. Establishing Komagataella phaffii as a cell factory for efficient production of cholesterol sulfate. ACS Sustain Chem Eng, 2024, 13(1): 174-186

[151] Xiong H, Yang X, Zhang W, Hu L, Liu G, Du G, Chen J, Li J, Xu R, Kang Z. Engineering Komagataella phaffii cell factories for the production of chondroitin sulfate A with high sulfation degree. Chem Eng J, 2025, 520: 165780

[152] Xiong J, Bhaskar U, Li G, Fu L, Li L, Zhang F, Dordick JS, Linhardt RJ. Immobilized enzymes to convert N-sulfo, N-acetyl heparosan to a critical intermediate in the production of bioengineered heparin. J Biotechnol, 2013, 167(3): 241-247

[153] Xi X, Hu L, Huang H, Wang Y, Xu R, Du G, Chen J, Kang Z. Improvement of the stability and catalytic efficiency of heparan sulfate N-sulfotransferase for preparing N-sulfated heparosan. J Ind Microbiol Biotechnol, 2023

[154] Xi X, Zhang W, Hu L, Xu R, Wang Y, Du G, Chen J, Kang Z. Enzymatic construction of a library of even- and odd-numbered heparosan oligosaccharides and their N-sulfonated derivatives. Int J Biol Macromol, 2024, 264(1): 130501

[155] Xu D, Moon AF, Song D, Pedersen LC, Liu J. Engineering sulfotransferases to modify heparan sulfate. Nat Chem Biol, 2008, 43200-202

[156] Xu D, Tiwari V, Xia G, Clement C, Shukla D, Liu J. Characterization of heparan sulphate 3-O-sulphotransferase isoform 6 and its role in assisting the entry of herpes simplex virus type 1. Biochem J, 2005, 385(Pt 2): 451-459

[157] Xu R, Wang Y, Huang H, Jin X, Li J, Du G, Kang Z. Closed-loop system driven by ADP phosphorylation from pyrophosphate affords equimolar transformation of atp to 3′-phosphoadenosine-5′-phosphosulfate. ACS Catal, 2021, 11(16): 10405-10415

[158] Xu R, Zhang W, Xi X, Chen J, Wang Y, Du G, Li J, Chen J, Kang Z. Engineering sulfonate group donor regeneration systems to boost biosynthesis of sulfated compounds. Nat Commun, 2023, 14(1): 7297

[159] Xu Y, Cai C, Chandarajoti K, Hsieh PH, Li L, Pham TQ, Sparkenbaugh EM, Sheng J, Key NS, Pawlinski R, Harris EN, Linhardt RJ, Liu J. Homogeneous low-molecular-weight heparins with reversible anticoagulant activity. Nat Chem Biol, 2014, 104248-250

[160] Xu Y, Masuko S, Takieddin M, Xu H, Liu R, Jing J, Mousa SA, Linhardt RJ, Liu J. Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins. Science (New York, NY), 2011, 334(6055): 498-501

[161] Xu Y, Moon AF, Xu S, Krahn JM, Liu J, Pedersen LC. Structure based substrate specificity analysis of heparan sulfate 6-O-sulfotransferases. ACS Chem Biol, 2017, 12(1): 73-82

[162] Xu Y, Pempe EH, Liu J. Chemoenzymatic synthesis of heparin oligosaccharides with both anti-factor Xa and anti-factor IIa activities. J Biol Chem, 2012, 287(34): 29054-29061

[163] Xu Z, Liu D, Zhu J, Zhao J, Shen S, Wang Y, Yu P. Catalysts for sulfur: understanding the intricacies of enzymes orchestrating plant sulfur anabolism. Planta, 2024, 261(1): 16

[164] Yang X, Wang Q, Zhang A, Shao X, Liu T, Tang B, Fang G. Strategies for sustained release of heparin: a review. Carbohydr Polym, 2022, 294: 119793

[165] Yu J, Zhang Y, Zhang H, Li Z, Li ZJ, Tan T. Coupling optimization of cell growth cycle and key enzyme membrane localization for enhanced synthesis of high molecular weight heparosan by Corynebacterium glutamicum. Bioresour Bioprocess, 2025, 12161

[166] Yu Y, Gong B, Wang H, Yang G, Zhou X. Chromosome evolution of Escherichia coli Nissle 1917 for high-level production of heparosan. Biotechnol Bioeng, 2023, 12041081-1096

[167] Zhang C, Liu L, Teng L, Chen J, Liu J, Li J, Du G, Chen J. Metabolic engineering of Escherichia coli BL21 for biosynthesis of heparosan, a bioengineered heparin precursor. Metab Eng, 2012, 14(5): 521-527

[168] Zhang L, Beeler DL, Lawrence R, Lech M, Liu J, Davis JC, Shriver Z, Sasisekharan R, Rosenberg RD. 6-O-sulfotransferase-1 represents a critical enzyme in the anticoagulant heparan sulfate biosynthetic pathway. J Biol Chem, 2001, 276(45): 42311-42321

[169] Zhang L, Wang H, Zhou Z, Du G, Chen J, Kang Z. Optimization of heparosan synthetic pathway in Bacillus subtilis 168. Chin J Biotechnol, 2017, 33(6): 936-945

[170] Zhang X, Pagadala V, Jester HM, Lim AM, Pham TQ, Goulas AMP, Liu J, Linhardt RJ. Chemoenzymatic synthesis of heparan sulfate and heparin oligosaccharides and NMR analysis: paving the way to a diverse library for glycobiologists. Chem Sci, 2017, 8(12): 7932-7940

[171] Zhang X, Xu Y, Hsieh PH, Liu J, Lin L, Schmidt EP, Linhardt RJ. Chemoenzymatic synthesis of unmodified heparin oligosaccharides: cleavage of p-nitrophenyl glucuronide by alkaline and Smith degradation. Org Biomol Chem, 2017, 15(5): 1222-1227

[172] Zhang Y, Guo S, Xu J. Multifunctional applications and research advances of low-molecular-weight heparin. Front Pharmacol, 2025, 16: 1585762

[173] Zhang Y, Wang Y, Zhou Z, Wang P, Xi X, Hu S, Ruirui X, Du G, Li J, Chen J, Kang Z. Synthesis of bioengineered heparin by recombinant yeast Pichia pastoris. Gr Chem, 2022

[174] Zhang Z, McCallum SA, Xie J, Nieto L, Corzana F, Jiménez-Barbero J, Chen M, Liu J, Linhardt RJ. Solution structures of chemoenzymatically synthesized heparin and its precursors. J Am Chem Soc, 2008, 130(39): 12998-13007

[175] Zhao C, Qian J, Chen X. Microbial engineering for natural and unnatural glycosaminoglycans biosynthesis. Nat Prod Rep, 2025

[176] Zhou Z, Li Q, Xu R, Wang B, Du G, Kang Z. Secretory expression of the rat aryl sulfotransferases IV with improved catalytic efficiency by molecular engineering. 3 Biotech, 2019, 9(6): 246

[177] Zhou Z, White KA, Polissi A, Georgopoulos C, Raetz CR. Function of Escherichia coli MsbA, an essential ABC family transporter, in lipid A and phospholipid biosynthesis. J Biol Chem, 1998, 2732012466-12475

Funding

National Key Research and Development Program of China(2021YFC2103200)

National Natural Science Foundation of China(22278361 and 22478341)

RIGHTS & PERMISSIONS

The Author(s)